Hadox Research Labs · Science Intelligence
We watch the research landscape, compare papers with fair peers, read the full text and publish the receipts. No journal logo, citation count or model gets the last word alone.
Current truthThe ascendance engine is still building history. This edition is editorially selected, not algorithmically declared “rising.”
Comparison universe1,138 current candidates across 41 age, field and article-type cohorts.
Evidence gateEvery public dossier was read from an authorised full body. Abstract-only records remain ineligible.
As of25 Jul 2026
This public, sanitized index unites the observatory with Hadox's reviewed dossiers. Bibliographic metadata and measured signal states are visible; abstracts and source text are not.
Tracking is not endorsement. A row means Hadox is monitoring the paper or has completed a public dossier. Radar states appear only when measured against age-, field- and article-type peers; no metric is invented for editorial selections.
Read the selection method| Paper | Field | Radar state | Attention | Next review | Hadox |
|---|---|---|---|---|---|
| Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with imipenem–cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00596-9 | Epidemiology Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 61% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00865-2 | Neurology Research article | Baseline Candidate · 1 signal point | 2 citations Cohort 70% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression Cell · 2026-05-01 · 10.1016/j.cell.2026.03.029 | Biochemistry, Genetics and Molecular Biology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 31% · 31 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| End of transplantation's reign in mantle cell lymphoma The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00556-8 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 30% · 65 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Enhanced Games begin amid scientific concerns The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)01020-2 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 30% · 65 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00463-0 | Medicine Research article | Baseline Candidate · 1 signal point | 4 citations Cohort 88% · 65 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| ErbB family receptor dimerization dynamics and dysregulation via long-term single-molecule imaging Cell · 2026-05-01 · 10.1016/j.cell.2026.04.010 | Oncology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 8% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Evidence into action: advancing liver health policy in the WHO European region The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00560-x | Epidemiology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 28% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Fabricated citations: an audit across 2·5 million biomedical papers The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00603-3 | Social Sciences Research article | Baseline Candidate · 1 signal point | 21 citations Cohort 98% · 20 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Genome instability triggers intercellular DNA transfer between human cells Cell · 2026-05-01 · 10.1016/j.cell.2026.04.041 | Molecular Biology Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 58% · 19 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Global challenges for research on gun violence The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00361-2 | Social Sciences Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 40% · 10 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| HPV vaccine scale-up is key to curb rising cervical cancer inequalities The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00498-8 | Epidemiology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 28% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Immune-microbiome coordination defines interferon setpoints in healthy humans Cell · 2026-05-01 · 10.1016/j.cell.2026.02.003 | Immunology Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 94% · 8 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Impact of introducing RTS,S/AS01E malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00248-5 | Public Health, Environmental and Occupational Health Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 50% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Long-term effects of colonoscopy screening on colorectal cancer incidence and mortality: a multicountry, population-based randomised controlled trial The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00508-8 | Oncology Research article | Baseline Candidate · 1 signal point | 2 citations Cohort 33% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
These are the exact visual editions already shared by Hadox. Each one now has a canonical source, immutable assets and a visible workflow state; publication history never substitutes for scientific review.
01
The source is identified, but no authorised full body is available for Hadox review yet.
02
Published edition linked to a full-text Hadox evidence dossier.
03
This official-source story is awaiting the institutional evidence workflow.
Historical copy retained; correction logged in the workflow.
Today, 0 papers have enough history for a momentum score and 0 public dossiers were selected by an open ascendance gate. That is not a failure to hide; it is the calibration state.
current paper assessments from Crossref + Openalex
cohorts split by paper age, article type and discipline
baseline · 1 watch · 0 rising
01Observe attention against fair peers.
02Wait for enough history to measure velocity.
03Read the authorised full paper and map every claim.
04Make a separate editorial decision and publish the evidence.